Literature DB >> 20218795

Increased xanthine oxidase in the thalamus and putamen in depression.

Tanja Maria Michel1, Sybille Camara, Thomas Tatschner, Sophia Frangou, Abigail Jane Sheldrick, Peter Riederer, Edna Grünblatt.   

Abstract

A growing body of literature suggests persistent and selective structural changes in the cortico-limbic-thalamic-striatal system in patients with recurrent depressive disorder (DD). Oxidative stress is thought to play a key role in these processes. So far, the main scientific focus has been on antioxidant enzymes in this context. For the first time, this proof of concept study examines the activity of the free radicals producing the enzyme, xanthine oxidase (XO), directly in the cortico-limbic-thalamic-striatal system of patients with recurrent depression. The activity of XO was ascertained in the cortico-limbic-thalamic-striatal regions in post-mortem brain tissue of patients with recurrent depressive episodes and individuals without any neurological or psychiatric history (7/7). We measured the XO activity in following brain areas: hippocampus, regio entorhinalis, thalamus, putamen and caudate nucleus. In this study, we report a significant increase of XO activity in the thalamus and the putamen of patients with depression. Our findings contribute to the growing body of evidence suggesting that oxidative stress plays a pivotal role in certain brain areas in recurrent depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20218795     DOI: 10.3109/15622970802123695

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  22 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

2.  Elevated serum xanthine oxidase activities in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-hong Zhang; Ying Gao
Journal:  Clin Rheumatol       Date:  2009-08-23       Impact factor: 2.980

3.  Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy.

Authors:  Inmaculada Tasset; René Drucker-Colín; José Peña; Ignacio Jimena; Pedro Montilla; Francisco Javier Medina; Isaac Túnez
Journal:  Neurochem Res       Date:  2010-04-29       Impact factor: 3.996

4.  Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.

Authors:  Eliane Brito Cortez Lima; Caren Nádia Soares de Sousa; Germana Silva Vasconcelos; Lucas Nascimento Meneses; Yuri Freitas E Silva Pereira; Naiara Coelho Ximenes; Manuel Alves Santos Júnior; Natália Castelo Branco Matos; Rayanne Brito; Diogo Miron; Luzia Kalyne Almeida Moreira Leal; Danielle Macêdo; Silvânia Maria Mendes Vasconcelos
Journal:  J Nat Med       Date:  2016-02-08       Impact factor: 2.343

5.  An effort toward molecular neuroeconomics of food deprivation induced food hoarding in mice: focus on xanthine oxidoreductase gene expression and xanthine oxidase activity.

Authors:  Isaac Karimi; Shima Motamedi; Lora A Becker
Journal:  Metab Brain Dis       Date:  2017-12-19       Impact factor: 3.584

Review 6.  Targeting inflammation: a potential approach for the treatment of depression.

Authors:  Shvetank Bhatt; Thangaraj Devadoss; Niraj Kumar Jha; Moushumi Baidya; Gaurav Gupta; Dinesh Kumar Chellappan; Sachin Kumar Singh; Kamal Dua
Journal:  Metab Brain Dis       Date:  2022-10-14       Impact factor: 3.655

Review 7.  DNA Damage in Major Psychiatric Diseases.

Authors:  Muhammad Ummear Raza; Turan Tufan; Yan Wang; Christopher Hill; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

Review 8.  Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

Authors:  Guilherme A Behr; José C F Moreira; Benicio N Frey
Journal:  Oxid Med Cell Longev       Date:  2012-05-27       Impact factor: 6.543

9.  Depression uncouples brain hate circuit.

Authors:  H Tao; S Guo; T Ge; K M Kendrick; Z Xue; Z Liu; J Feng
Journal:  Mol Psychiatry       Date:  2011-10-04       Impact factor: 15.992

Review 10.  Markers of Oxidative Stress and Neuroprogression in Depression Disorder.

Authors:  Magdaléna Vaváková; Zdeňka Ďuračková; Jana Trebatická
Journal:  Oxid Med Cell Longev       Date:  2015-05-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.